A股異動 | 和而泰(002402.SZ)漲逾8% 推股權激勵計劃獲券商看好
格隆匯2月1日丨和而泰(002402.SZ)股價高位震盪,盤中最高見21.74元觸及漲停,現報21.39元,漲幅8.25%,最新總市值195.5億,換手率6.6%。公司上月29日公吿稱,擬向172名激勵對象授1,500萬份股票期權,佔本次計劃公吿時股本總額的1.64%,股票期權的首次行權價格為19.76元/股。申萬宏源認為,股權激勵計劃彰顯公司發展信心,且公司兩大業務均具備高增長潛力,各項業務拓展進度順利,上調20-22年歸母淨利潤至4.10/5.86/8.00億元(此前預測值為3.69/5.26/7.11億元),當前股價對應PE為44x、31x、22x,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.